These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 21594787)

  • 21. Post-translational modifications of CFTR: insight into protein trafficking and cystic fibrosis disease.
    Amaral MD; Farinha CM
    FEBS J; 2013 Sep; 280(18):4395. PubMed ID: 23680006
    [No Abstract]   [Full Text] [Related]  

  • 22. The biophysics, biochemistry and physiology of CFTR.
    Moran O
    Cell Mol Life Sci; 2017 Jan; 74(1):1-2. PubMed ID: 27704173
    [No Abstract]   [Full Text] [Related]  

  • 23. Introduction to section II: omics in the biology of cystic fibrosis.
    Balch WE
    Methods Mol Biol; 2011; 742():189-91. PubMed ID: 21547733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosis.
    Gelman MS; Kopito RR
    J Clin Invest; 2002 Dec; 110(11):1591-7. PubMed ID: 12464661
    [No Abstract]   [Full Text] [Related]  

  • 25. Cystic fibrosis: five years beyond the gene.
    Porteous DJ
    J Inherit Metab Dis; 1995; 18(4):491-4. PubMed ID: 7494406
    [No Abstract]   [Full Text] [Related]  

  • 26. Cystic fibrosis year in review 2019: Section 2 pulmonary disease and infections.
    Savant AP; McColley SA
    Pediatr Pulmonol; 2023 Mar; 58(3):672-682. PubMed ID: 32970381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cystic fibrosis: a rare disease emerging in China.
    Zhang T; Tian X; Xu KF
    Sci China Life Sci; 2020 Jul; 63(7):1082-1084. PubMed ID: 32103413
    [No Abstract]   [Full Text] [Related]  

  • 28. CFTR crystals.
    Weitzman J
    Trends Mol Med; 2001 Apr; 7(4):149. PubMed ID: 11286931
    [No Abstract]   [Full Text] [Related]  

  • 29. References to commonly used techniques.
    Curr Protoc Nucleic Acid Chem; 2001 May; Appendix 3():Appendix 3A. PubMed ID: 18428810
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sorting on arXiv: Introduction to an ad hoc section.
    Sismondo S
    Soc Stud Sci; 2016 Aug; 46(4):583-585. PubMed ID: 28948869
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro CFTR folding assays.
    Stidham RD; Wigley WC; Thomas PJ
    Methods Mol Med; 2002; 70():311-22. PubMed ID: 11917534
    [No Abstract]   [Full Text] [Related]  

  • 32. Molecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies.
    Odolczyk N; Zielenkiewicz P
    Int J Biochem Cell Biol; 2014 Jul; 52():39-46. PubMed ID: 24735712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introduction to section III: biochemical methods to study CFTR protein.
    Amaral MD; Lukacs GL
    Methods Mol Biol; 2011; 741():213-8. PubMed ID: 21594787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction to section III: resources for CFTR research.
    Amaral MD
    Methods Mol Biol; 2011; 742():281-3. PubMed ID: 21547739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Turnover of the cystic fibrosis transmembrane conductance regulator (CFTR): slow degradation of wild-type and delta F508 CFTR in surface membrane preparations of immortalized airway epithelial cells.
    Wei X; Eisman R; Xu J; Harsch AD; Mulberg AE; Bevins CL; Glick MC; Scanlin TF
    J Cell Physiol; 1996 Aug; 168(2):373-84. PubMed ID: 8707873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macromolecular complexes of cystic fibrosis transmembrane conductance regulator and its interacting partners.
    Li C; Naren AP
    Pharmacol Ther; 2005 Nov; 108(2):208-23. PubMed ID: 15936089
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.